Heterocycle amino alkyloxy substituted quinazoline derivatives as represented by the structural Formula (I) and pharmaceutically acceptable salts thereof, capable of inhibiting the activity of receptor tyrosine kinase EGFR, and being used to treat cancers related to the expression of the receptor tyrosine kinase of the ErbB family are provided.
本发明提供了由结构式(I)表示的杂环
氨基烷氧基取代的
喹唑啉衍
生物及其药学上可接受的盐,它们能够抑制受体
酪氨酸激酶
表皮生长因子受体的活性,并可用于治疗与表达 ErbB 家族受体
酪氨酸激酶有关的癌症。